Padagis Israel Pharmaceuticals Ltd
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Israel
- Registered address
- 1 Burnstein Zvi, Yeruham, 8050315, Israel (ISR)
- Operations here
- manufacture
- FDA identifiers
- FEI 3001904238 · DUNS 600093611
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2022-10-27
- NAIBioresearch Monitoring2019-06-13
- NAIDrug Quality Assurance2018-07-19
- VAIDrug Quality Assurance2015-01-22
- VAIDrug Quality Assurance2012-08-27
- NAIDrug Quality Assurance2010-01-28
Drugs this plant is listed as making
6 distinct drugs across 6 products name this site in their FDA label.
- clindamycin phosphatein shortageMedimetriks Pharmaceuticals, Inc.
- clindamycin phosphate and benzoyl peroxideMedimetriks Pharmaceuticals
- Clobetasol PropionateMedimetriks Pharmaceuticals, Inc.
- ketoconazoleMedimetriks Pharmaceuticals, Inc.
- Triamcinolone AcetonidePadagis Israel Pharmaceuticals Ltd
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.